InterCure Acquires 28% Stake in Cannasoul
I'm PortAI, I can summarize articles.
InterCure Ltd. has acquired a 28% stake in Cannasoul R&D Ltd. through a Share Purchase Agreement, with an option to increase its ownership to 51% within two years. This investment aims to enhance cannabis science and pharmaceutical innovation by leveraging Cannasoul’s research and InterCure’s platform. The deal is subject to regulatory approvals and customary closing conditions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments